<DOC>
	<DOCNO>NCT00432068</DOCNO>
	<brief_summary>This study assess pharmacokinetic profile , safety tolerability octreotide extend long-acting formulation single dose human . It investigate profile single dose drug healthy volunteer subject order understand time extent fluctuation octreotide concentration blood formulation , relationship drug concentration dose , long drug remain body system .</brief_summary>
	<brief_title>Open Label Study Single Dose New Extended Long Acting Formulation Octreotide Pamoate Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Octreotide</mesh_term>
	<criteria>Inclusion criterion : Male female 1860 year age , cholecystectomized least 4 month prior start study . In good health determine past medical history , physical examination , vital sign , electrocardiogram laboratory test screen Body mass index within 1929 kg/m2 Able communicate well investigator comply requirement study . Exclusion criterion : Any clinically significant abnormal laboratory value screen , evidence clinically significant abnormal finding physical exam screening , significant illness within 2 week prior dose A past medical history clinically significant ECG abnormality family history prolong QTinterval syndrome History acute chronic bronchospastic disease ( include asthma chronic obstructive pulmonary disease , treat untreated ) History clinically significant drug allergy , history atopic allergy , history clinical evidence pancreatic injury pancreatitis , clinical evidence liver disease liver injury , history presence impair renal function , history urinary obstruction difficulty urinate History immunocompromise , include positive HIV Known positive hepatitis B C surface antigen ( HBsAg ) Hepatitis C test result ( antiHCV ) History drug alcohol abuse within 12 month prior dose evidence abuse indicate laboratory assay screen Female subject pregnant lactating , childbearing potential without medically acceptable highly effective method birth control . Demonstrating intolerance octreotide baseline Any subject know history diabetes mellitus parent grandparent . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Healthy volunteer</keyword>
	<keyword>octreotide pamoate</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>